Click for best price
Postpemic Era Molecular Diagnostics Market Size, Share 2022
Summary
The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.
2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.
According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.
Global Molecular Diagnostics Market Segment Research Report 2022?, which aims to sort out the development status and trends of the Molecular Diagnostics industry at home and abroad, estimate the overall market scale of the Molecular Diagnostics industry and the market share of major countries, Molecular Diagnostics industry, and study and judge the downstream market demand of Molecular Diagnostics through systematic research, Analyze the competition pattern of Molecular Diagnostics, so as to help solve the pain points of various stakeholders in Molecular Diagnostics industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.
Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of Molecular Diagnostics Market by XYZResearch Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Molecular Diagnostics Market?
Agilent Technologies
BD
Bio-Rad Laboratories
Danaher
F. Hoffmann-La Roche
Eppendorf
PerkinElmer
Tecan Group
Thermo Fisher Scientific
QIAGEN
Major Type of Molecular Diagnostics Covered in XYZResearch report:
Real Time- PCR Systems
Liquid Handling System
NA Extraction System
Application Segments Covered in XYZResearch Market
Hospitals
Diagnostic Laboratories
Academic and Research Institutes
Pharmaceutical and Biotechnology Companies
For any other requirements, please feel free to contact us and we will provide you customized report.
| Report Attributes |
Report Details |
| Report Title |
(Post-pandemic Era)-Global Molecular Diagnostics Market Segment Research Report 2022 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
83 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
Table of Contents
Global Molecular Diagnostics Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Molecular Diagnostics Market by Value
2.2.1 Global Molecular Diagnostics Revenue by Type
2.2.2 Global Molecular Diagnostics Market by Value
2.3 Global Molecular Diagnostics Market by Sales
2.3.1 Global Molecular Diagnostics Sales by Type
2.3.2 Global Molecular Diagnostics Market by Sales
3. The Major Driver of Molecular Diagnostics Industry
3.1 Historical & Forecast Global Molecular Diagnostics Sales and Revenue (2018-2028)
3.2 Largest Application for Molecular Diagnostics (2018-2028)
3.3 The Major Downstream Company in China Market 2022
4. Global and Regional Molecular Diagnostics Market
4.1 Regional Market Size in Terms of Sales (2022 & 2028)
4.2 Regional Market Share in Terms of Revenue (2022 & 2028)
4.3 Concentration Ratio (CR5& CR10) of Molecular Diagnostics Market
4.4 Mergers & Acquisitions, Expansion Plans
5. US Molecular Diagnostics Sales (2018-2028)
5.1 Current and Estimated Sales Breakdown by Type (2018-2028)
5.2 Current and Estimated Sales Breakdown by Application (2018-2028)
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
6. Europe Molecular Diagnostics Sales (2018-2028)
6.1 Current and Estimated Sales Breakdown by Type (2018-2028)
6.2 Current and Estimated Sales Breakdown by Application (2018-2028)
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
7. China Molecular Diagnostics Sales (2018-2028)
7.1 Current and Estimated Sales Breakdown by Type (2018-2028)
7.2 Current and Estimated Sales Breakdown by Application (2018-2028)
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
8. Japan Molecular Diagnostics Sales (2018-2028)
8.1 Current and Estimated Sales Breakdown by Type (2018-2028)
8.2 Current and Estimated Sales Breakdown by Application (2018-2028)
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
9. India Molecular Diagnostics Sales (2018-2028)
9.1 Current and Estimated Sales Breakdown by Type (2018-2028)
9.2 Current and Estimated Sales Breakdown by Application (2018-2028)
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
10. Korea Molecular Diagnostics Sales (2018-2028)
10.1 Current and Estimated Sales Breakdown by Type (2018-2028)
10.2 Current and Estimated Sales Breakdown by Application (2018-2028)
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
11. Southeast Asia Molecular Diagnostics Sales (2018-2028)
11.1 Current and Estimated Sales Breakdown by Type (2018-2028)
11.2 Current and Estimated Sales Breakdown by Application (2018-2028)
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
12. South America Molecular Diagnostics Sales (2018-2028)
12.1 Current and Estimated Sales Breakdown by Type (2018-2028)
12.2 Current and Estimated Sales Breakdown by Application (2018-2028)
12.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
12.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
13. Global Molecular Diagnostics Average Price Trend
13.1 Market Price for Each Type of Molecular Diagnostics in US (2018-2022)
13.2 Market Price for Each Type of Molecular Diagnostics in Europe (2018-2022)
13.3 Market Price for Each Type of Molecular Diagnostics in China (2018-2022)
13.4 Market Price for Each Type of Molecular Diagnostics in Japan (2018-2022)
13.5 Market Price for Each Type of Molecular Diagnostics in India (2018-2022)
13.6 Market Price for Each Type of Molecular Diagnostics in Korea (2018-2022)
13.7 Market Price for Each Type of Molecular Diagnostics in Southeast Asia (2018-2022)
13.8 Market Price for Each Type of Molecular Diagnostics in South America (2018-2022)
14. Industrial Chain (Impact of COVID-19)
14.1 Molecular Diagnostics Industrial Chain Analysis
14.2 Downstream
14.3 Impact of COVID-19
14.4 Post-pandemic Era
14.5 Technology Trends of Molecular Diagnostics
15. Molecular Diagnostics Competitive Landscape
15.1 Agilent Technologies
15.1.1 Agilent Technologies Company Profiles
15.1.2 Agilent Technologies Product Introduction
15.1.3 Agilent Technologies Molecular Diagnostics Sales, Revenue (2018-2022)
15.1.4 Strategic initiatives
15.2 BD
15.2.1 BD Company Profiles
15.2.2 BD Product Introduction
15.2.3 BD Molecular Diagnostics Sales, Revenue (2018-2022)
15.2.4 Strategic initiatives
15.3 Bio-Rad Laboratories
15.3.1 Bio-Rad Laboratories Company Profiles
15.3.2 Bio-Rad Laboratories Product Introduction
15.3.3 Bio-Rad Laboratories Molecular Diagnostics Sales, Revenue (2018-2022)
15.3.4 Strategic initiatives
15.4 Danaher
15.4.1 Danaher Company Profiles
15.4.2 Danaher Product Introduction
15.4.3 Danaher Molecular Diagnostics Sales, Revenue (2018-2022)
15.4.4 Strategic initiatives
15.5 F. Hoffmann-La Roche
15.5.1 F. Hoffmann-La Roche Company Profiles
15.5.2 F. Hoffmann-La Roche Product Introduction
15.5.3 F. Hoffmann-La Roche Molecular Diagnostics Sales, Revenue (2018-2022)
15.5.4 Strategic initiatives
15.6 Eppendorf
15.6.1 Eppendorf Company Profiles
15.6.2 Eppendorf Product Introduction
15.6.3 Eppendorf Molecular Diagnostics Sales, Revenue (2018-2022)
15.6.4 Strategic initiatives
15.7 PerkinElmer
15.7.1 PerkinElmer Company Profiles
15.7.2 PerkinElmer Product Introduction
15.7.3 PerkinElmer Molecular Diagnostics Sales, Revenue (2018-2022)
15.7.4 Strategic initiatives
15.8 Tecan Group
15.8.1 Tecan Group Company Profiles
15.8.2 Tecan Group Product Introduction
15.8.3 Tecan Group Molecular Diagnostics Sales, Revenue (2018-2022)
15.8.4 Strategic initiatives
15.9 Thermo Fisher Scientific
15.9.1 Thermo Fisher Scientific Company Profiles
15.9.2 Thermo Fisher Scientific Product Introduction
15.9.3 Thermo Fisher Scientific Molecular Diagnostics Sales, Revenue (2018-2022)
15.9.4 Strategic initiatives
15.10 QIAGEN
15.10.1 QIAGEN Company Profiles
15.10.2 QIAGEN Product Introduction
15.10.3 QIAGEN Molecular Diagnostics Sales, Revenue (2018-2022)
15.10.4 Strategic initiatives
16. Conclusion
17. Methodology and Data Source
LIST OF TABLES & FIGURES
List of Tables and Figures
Figure 1. Total Sales by Application of Molecular Diagnostics Industry (Volume)
Figure 2. Molecular Diagnostics Sales by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2028)
Figure 4. The Top 10 and 5 Players Market Share by Molecular Diagnostics Revenue in 2022
Figure 5. US Molecular Diagnostics Sales (2018-2028)
Figure 6. Sales Breakdown by Type (%)
Figure 7. Sales Breakdown by Type (%)
Figure 8. Sales Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Molecular Diagnostics Sales (2018-2028)
Figure 12. Sales Breakdown by Type (%)
Figure 13. Sales Breakdown by Type (%)
Figure 14. Sales Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Molecular Diagnostics Sales (2018-2028)
Figure 18. Sales Breakdown by Type (%)
Figure 19. Sales Breakdown by Type (%)
Figure 20. Sales Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Molecular Diagnostics Sales (2018-2028)
Figure 25. Sales Breakdown by Type (%)
Figure 26. Sales Breakdown by Type (%)
Figure 27. Sales Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Molecular Diagnostics Sales (2018-2028)
Figure 31. Sales Breakdown by Type (%)
Figure 32. Sales Breakdown by Type (%)
Figure 33. Sales Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Molecular Diagnostics Sales (2018-2028)
Figure 37. Sales Breakdown by Type (%)
Figure 38. Sales Breakdown by Type (%)
Figure 39. Sales Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Molecular Diagnostics Sales (2018-2028)
Figure 43. Current and Estimated Sales Breakdown by Type (2018-2028)
Figure 44. Sales Breakdown by Type (%)
Figure 45. Sales Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Molecular Diagnostics Revenue, by Type (Million USD) (2018-2028)
Table 4. Molecular Diagnostics Sales, by Type (K Unit) (2018-2028)
Table 5. Molecular Diagnostics Sales (K Unit) by Application (2018-2028)
Table 6. Molecular Diagnostics Sales (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Sales (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2028)
Table 10. Ranking of Global Top Molecular Diagnostics Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Molecular Diagnostics Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 13. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 14. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 15. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Molecular Diagnostics Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 19. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 20. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 21. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Molecular Diagnostics Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 25. Table Current and Estimated Sales Breakdown by Type
Table 26. Current and Estimated Sales Breakdown by Type
Table 27. Current and Estimated Sales Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Molecular Diagnostics Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 30. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 31. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 32. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Molecular Diagnostics Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 36. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 37. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 38. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Molecular Diagnostics Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 42. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 43. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 44. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Molecular Diagnostics Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 48. Table Current and Estimated Sales Breakdown by Type (2018-2028)
Table 49. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Molecular Diagnostics in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Molecular Diagnostics in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Molecular Diagnostics in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Molecular Diagnostics in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Molecular Diagnostics in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Molecular Diagnostics in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Molecular Diagnostics in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Agilent Technologies Profiles
Table 61. Agilent Technologies Molecular Diagnostics Product Introduction
Table 62. Agilent Technologies Molecular Diagnostics Sales (Unit), Revenue (Million USD) (2018-2022)
Table 63. Agilent Technologies Strategic initiatives
Table 64. BD Profiles
Table 65. BD Molecular Diagnostics Product Introduction
Table 66. BD Molecular Diagnostics Sales (Unit), Revenue (Million USD) (2018-2022)
Table 67. BD Strategic initiatives
Table 68. Bio-Rad Laboratories Profiles
Table 69. Bio-Rad Laboratories Molecular Diagnostics Product Introduction
Table 70. Bio-Rad Laboratories Molecular Diagnostics Sales (Unit), Revenue (Million USD) (2018-2022)
Table 71. Bio-Rad Laboratories Strategic initiatives
Table 72. Danaher Profiles
Table 73. Danaher Molecular Diagnostics Product Introduction
Table 74. Danaher Molecular Diagnostics Sales (Unit), Revenue (Million USD) (2018-2022)
Table 75. Danaher Strategic initiatives
Table 76. F. Hoffmann-La Roche Profiles
Table 77. F. Hoffmann-La Roche Molecular Diagnostics Product Introduction
Table 78. F. Hoffmann-La Roche Molecular Diagnostics Sales (Unit), Revenue (Million USD) (2018-2022)
Table 79. F. Hoffmann-La Roche Strategic initiatives
Table 80. Eppendorf Profiles
Table 81. Eppendorf Molecular Diagnostics Product Introduction
Table 82. Eppendorf Molecular Diagnostics Sales (Unit), Revenue (Million USD) (2018-2022)
Table 83. Eppendorf Strategic initiatives
Table 84. PerkinElmer Profiles
Table 85. PerkinElmer Molecular Diagnostics Product Introduction
Table 86. PerkinElmer Molecular Diagnostics Sales (Unit), Revenue (Million USD) (2018-2022)
Table 87. PerkinElmer Strategic initiatives
Table 88. Tecan Group Profiles
Table 89. Tecan Group Molecular Diagnostics Product Introduction
Table 90. Tecan Group Molecular Diagnostics Sales (Unit), Revenue (Million USD) (2018-2022)
Table 91. Tecan Group Strategic initiatives
Table 92. Thermo Fisher Scientific Profiles
Table 93. Thermo Fisher Scientific Molecular Diagnostics Product Introduction
Table 94. Thermo Fisher Scientific Molecular Diagnostics Sales (Unit), Revenue (Million USD) (2018-2022)
Table 95. Thermo Fisher Scientific Strategic initiatives
Table 97. QIAGEN Profiles
Table 98. QIAGEN Molecular Diagnostics Product Introduction
Table 99. QIAGEN Molecular Diagnostics Sales (Unit), Revenue (Million USD) (2018-2022)
Table 100. QIAGEN Strategic initiatives
